4-Amino-6-(1-(2-methoxyphenyl)-1H-pyrrolo[2,3-b]pyridin-5-yl)-7,8-dihydropyrimido[5,4-f][1,4]oxazepin-5(6H)-one

Catalog No. :
ACDKTR858
CAS No. :
1415344-89-6
Molecular Formula :
C21H18N6O3
Molecular Weight :
402.41

IUPAC Name:4-amino-6-(1-(2-methoxyphenyl)-1H-pyrrolo[2,3-b]pyridin-5-yl)-7,8-dihydropyrimido[5,4-f][1,4]oxazepin-5(6H)-one

4-Amino-6-(1-(2-methoxyphenyl)-1H-pyrrolo[2,3-b]pyridin-5-yl)-7,8-dihydropyrimido[5,4-f][1,4]oxazepin-5(6H)-one structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-Amino-6-(1-(2-methoxyphenyl)-1H-pyrrolo[2,3-b]pyridin-5-yl)-7,8-dihydropyrimido[5,4-f][1,4]oxazepin-5(6H)-one
IUPAC Name4-amino-6-(1-(2-methoxyphenyl)-1H-pyrrolo[2,3-b]pyridin-5-yl)-7,8-dihydropyrimido[5,4-f][1,4]oxazepin-5(6H)-one
Molecular FormulaC21H18N6O3
Molecular Weight402.41
SMILESO=C1N(C2=CN=C(N(C3=CC=CC=C3OC)C=C4)C4=C2)CCOC5=NC=NC(N)=C15
InChI KeyAXZMFHCSKVDPLV-UHFFFAOYSA-N
Synonym4-amino-6-[1-(2-methoxyphenyl)-1H-pyrrolo[2,3-b]pyridin-5-yl]-5H,6H,7H,8H-pyrimido[5,4-f][1,4]oxazepin-5-one;Pyrimido[5,4-f][1,4]oxazepin-5(6H)-one, 4-amino-7,8-dihydro-6-[1-(2-methoxyphenyl)-1H-pyrrolo[2,3-b]pyridin-5-yl]-
CAS No.1415344-89-6

Synthetic Route by SureRoute

1. ACDKTR858 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACEMIC570 route compound structure diagram
    ACEMIC5705720-06-9 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACDKTR858 route product structure diagram
    ACDKTR8581415344-89-6
Inquiry

2. ACDKTR858 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACDKTR858 route product structure diagram
    ACDKTR8581415344-89-6
Inquiry

Comments (0)